A Muticenter Clinical Study of Chinese Herbal Compound TJAOA102 in Alleviating Menopausal Syndrome
Status:
Not yet recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
Currently, TCM recipes are widely used in treating menopausal syndrome(MS) with obvious
efficiency and slight side effects. We have developed the Chinese herbal compound TJAOA102
and has validated its effects in animals. Here, we will perform a population-based,
multicenter study to confirm the safety and efficacy of TJAOA102 in therapy of MS, which will
provide a solid evidence for TCM in therapy of MS.